COVID Cicada Variant Hits 23 Countries — One Covers It

A hyper-mutated COVID-19 variant called Cicada (BA.3.2) has spread to at least 23 countries and now accounts for 30% of cases in Denmark, Germany, and the Netherlands. The CDC is tracking it across 25 US states. But here's what makes it an Albis story: only one region on Earth is covering it. The Global Attention Index scores Cicada at 6.64 — the highest invisibility rating this cycle — meaning 5.9 billion people, 94% of the world's population, have no meaningful awareness that this variant exists.

A virus born in South Africa is tearing through Europe and nobody outside America is talking about it.

BA.3.2 was first identified in a respiratory sample from a five-year-old child in South Africa in November 2024. It descended from the older BA.3 Omicron subvariant — a lineage scientists assumed had fizzled out in early 2022. Like its insect namesake, it spent over a year underground before resurfacing. When it did, it carried 70 to 75 mutations in its spike protein, making it one of the most genetically distinct COVID strains since the original Omicron wave.

Cases began climbing worldwide in September 2025. By January, Cicada represented roughly 30% of all sequenced COVID cases in Germany, Denmark, and the Netherlands. The CDC confirmed detection in wastewater samples from 132 sites across 25 US states as of February 11. The WHO classified it as a "variant under monitoring" in December 2025.

The gap between spreading and seeing

Here's where the story fractures.

Every major US outlet — USA Today, NBC, CDC reports, local papers — is running Cicada coverage. Symptoms, maps, vaccine guidance. The American public health machine, even with proposed $4 billion in CDC budget cuts, is tracking this closely.

But step outside the US, and the story vanishes. Europe, where Cicada is actually most dominant, has minimal English-language coverage of its own outbreak. The Middle East, South Asia, Asia-Pacific, Latin America, and Africa — regions representing 5.9 billion people — are publishing effectively nothing.

This isn't because those regions don't have cases. The CDC's own MMWR report confirms BA.3.2 has been detected across Africa, Asia, Europe, North America, and Oceania. The variant was literally born in Africa. It's circulating on five continents. But genomic surveillance — the ability to detect, sequence, and report variants — requires expensive technology and trained staff that most of the world doesn't have.

War ate the surveillance budget

The timing couldn't be worse.

The Iran war's cascading effects have stretched health systems to their limits. Sudan's health infrastructure is 80% destroyed, with 519 facilities attacked and patients traveling 500 kilometres for basic care. The WHO's own February 2026 pandemic preparedness report admitted the world remains dangerously underequipped.

Then America walked. On January 22, 2026, the US formally exited the World Health Organization. The Infectious Diseases Society of America warned the withdrawal means the US will no longer participate in the Global Influenza Surveillance and Response System — the backbone of international pathogen tracking.

So the country with the best COVID surveillance just left the body that coordinates global surveillance, while a hyper-mutated variant spreads through countries that can't see it, during a war that has gutted the health systems that would normally catch it.

Colorado has joined the WHO network independently. One state, filling the gap left by an entire federal government.

What the numbers actually say

The good news: there's currently no evidence BA.3.2 causes more severe illness or higher death rates than other circulating variants. Updated 2025-2026 vaccines still protect against severe disease, hospitalisation, and death. Antivirals like Paxlovid remain effective. The world is better equipped medically than it was in 2020.

The bad news is structural. Two BA.3.2 sublineages — BA.3.2.1 and BA.3.2.2 — have already been identified, indicating ongoing viral evolution. Seventy-five spike mutations give it strong potential for immune escape. And the populations least equipped to track it are the ones most exposed to health system collapse from the war.

The Perception Gap Index tells one side of this story: US coverage frames Cicada as a manageable public health matter — track it, update vaccines, move on. There's no urgency, because American health infrastructure can absorb it.

But that frame depends on your hospital being open. It depends on your country sequencing its wastewater. It depends on someone counting.

The attention problem

Every pandemic lesson from 2020 said the same thing: early global surveillance saves lives. Detect it early, share data widely, respond before it becomes uncontrollable.

Cicada is a real-time test of whether those lessons stuck. A variant born in South Africa, dominant in Northern Europe, tracked closely by one country, and invisible to six billion people.

The WHO's December classification happened three months ago. The CDC's detailed report came out March 19. Yet the story remains quarantined inside American media.

For context: when BA.3.2 was first detected, the world wasn't at war. Iran's Strait of Hormuz wasn't blockaded. Oil wasn't above $110. The UN hadn't yet built a humanitarian corridor to move fertiliser. Health budgets weren't being raided to fund energy emergencies. Surveillance infrastructure wasn't collapsing under the weight of displacement.

Now all of those things are true. And the variant keeps spreading.

Who's not seeing this

The Albis Global Attention Index measures which stories the world isn't seeing. Cicada scores 6.64 — Information Shadow tier. That means:

• Coverage breadth: 1 of 7 regions (US only)
• Population in blind regions: 5.87 billion people (94%)
• Regions absent: Europe, Middle East, South Asia, Asia-Pacific, Latin America, Africa

The most striking absence is Europe. Germany, Denmark, and the Netherlands have the highest Cicada case rates on Earth — 30% of sequenced samples. But European English-language media barely covers its own outbreak. The people most exposed have the least awareness.

This is what a surveillance gap looks like when it's not just about lab capacity. It's about attention. The war has consumed every headline. Oil prices, missile strikes, nuclear escalation, food crises — there's no room left for a virus that doesn't kill dramatically.

Cicada doesn't need to be deadly to matter. It needs to be watched. Right now, almost nobody is watching.

---

This story was identified by the Albis Global Attention Index — measuring which stories the world isn't seeing. Explore today's blind spots →